Editorial
doi: 10.1016/j.chest.2018.01.030.
Epub 2018 Feb 2.
COUNTERPOINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV1 < 50% Predicted) COPD? No
Affiliations
- PMID: 29410364
- DOI: 10.1016/j.chest.2018.01.030
Item in Clipboard
Editorial
COUNTERPOINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV1 < 50% Predicted) COPD? No
Chest.
2018 Apr.
No abstract available
Comment in
-
Rebuttal From Dr Chalmers.Chest. 2018 Apr;153(4):785-786. doi: 10.1016/j.chest.2018.01.036. Epub 2018 Feb 21. Chest. 2018. PMID: 29474808 No abstract available.
Similar articles
-
POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV1 < 50% Predicted) COPD? Yes.Chest. 2018 Apr;153(4):778-782. doi: 10.1016/j.chest.2018.01.029. Epub 2018 Feb 21. Chest. 2018. PMID: 29474807 No abstract available.
-
COUNTERPOINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? No.Chest. 2018 Oct;154(4):749-751. doi: 10.1016/j.chest.2018.06.024. Chest. 2018. PMID: 30290926 No abstract available.
-
Inhaled treatment of COPD: a Delphi consensus statement.Int J Chron Obstruct Pulmon Dis. 2017 Mar 6;12:793-801. doi: 10.2147/COPD.S125564. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28293106 Free PMC article.
-
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.Int J Chron Obstruct Pulmon Dis. 2017 Mar 17;12:907-922. doi: 10.2147/COPD.S130482. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28360514 Free PMC article. Review.
-
[Medical treatment of COPD].Ugeskr Laeger. 2013 Apr 29;175(18):1261-4. Ugeskr Laeger. 2013. PMID: 23651802 Review. Danish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
